ADAP
Adaptimmune Therapeutics PLC
Price:
0.25
USD
Volume:
459,962
United Kingdom | Biotechnology
ADAP Net Margin
As of 2025-07-03, the Net Margin of Adaptimmune Therapeutics PLC (ADAP) is -39.8%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
ADAP Net Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | -39.8% |
| 2023-12-31 | -188.9% |
| 2022-12-31 | -609.4% |
| 2021-12-31 | -2570.6% |
| 2020-12-31 | -3285.1% |
| 2019-12-31 | -12247.3% |
| 2018-12-31 | -160.5% |
| 2017-12-31 | -185.4% |
| 2016-12-31 | -504.1% |
| 2015-06-30 | -201.4% |
ADAP Net Margin - Peers Comparison